Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 11(1): 11248, 2021 05 27.
Article in English | MEDLINE | ID: mdl-34045571

ABSTRACT

The myeloid inhibitory receptor CLEC12A negatively regulates inflammation. Reduced CLEC12A expression enhances inflammation in CLEC12A knock-out mice with collagen antibody-induced arthritis. Moreover, CLEC12A internalisation augments human neutrophil activation. We thus postulated that CLEC12A expression on circulating myeloid cells of rheumatoid arthritis patients is associated with disease manifestations. Cell-surface, CLEC12A receptor expression was determined on circulating neutrophils and monocytes of eRA patients and of healthy donors. Generalized estimating equations model, Student's t-test and Spearman's correlations were performed to compare CLEC12A expression between groups and test its association with disease activity and clinical parameters. Plasma cytokines were measured by multiplex immunoassay. Patients with reduced neutrophil or monocyte CLEC12A expression at baseline and at 3 months have an increased simple disease activity index. Low baseline CLEC12A expression also correlates with a higher SDAI at 6 months. In contrast, positive correlations were observed between baseline CLEC12A expression and several cytokines. Moreover, neutrophil and monocyte CLEC12A expression is significantly higher in early rheumatoid arthritis patients at baseline than healthy controls. Circulating neutrophil and monocyte CLEC12A expression correlates with disease activity at baseline and is predictive of SDAI at later stages of the disease indicative of a regulatory role for CLEC12A in RA.


Subject(s)
Arthritis, Rheumatoid/metabolism , Cytokines/blood , Lectins, C-Type/metabolism , Myeloid Cells/metabolism , Receptors, Mitogen/metabolism , Aged , Arthritis, Rheumatoid/diagnosis , Female , Humans , Male , Middle Aged , Monocytes/metabolism , Neutrophil Activation , Neutrophils/metabolism , Severity of Illness Index
2.
J Rheumatol ; 33(5): 928-38, 2006 May.
Article in English | MEDLINE | ID: mdl-16652423

ABSTRACT

OBJECTIVE: To determine the presence and characterize the activity of a soluble activation factor rapidly released by human neutrophils after stimulation with monosodium urate (MSU) crystals. METHODS: Supernatants from human neutrophils stimulated by MSU crystals for 5 to 60 min were tested for their ability to stimulate a chemotactic response, induce a mobilization of calcium, and increase the tyrosine phosphorylation levels in naive neutrophils. RESULTS: Supernatant from neutrophils stimulated

Subject(s)
Interleukin-8/metabolism , Neutrophil Activation , Neutrophils/metabolism , Uric Acid/pharmacology , Calcium/metabolism , Chemotaxis, Leukocyte , Crystallization , Humans , Interleukin-8/pharmacology , Leukotriene B4/pharmacology , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Neutrophils/drug effects , Pertussis Toxin/pharmacology , Phosphorylation , Platelet Activating Factor/pharmacology , Receptors, Formyl Peptide/antagonists & inhibitors , Tyrosine/metabolism , Tyrosine/physiology
3.
J Immunol ; 170(10): 5235-43, 2003 May 15.
Article in English | MEDLINE | ID: mdl-12734372

ABSTRACT

Tyrosine phosphorylation events play major roles in the initiation and regulation of several functional responses of human neutrophils stimulated by chemotactic factors such as the bacterially derived tripeptide formylmethionyl-leucyl-phenylalanine (fMet-Leu-Phe). However, the links between the G protein-coupled receptors, the activation of the tyrosine kinases, and the initiation of neutrophil functional responses remain unclear. In the present study we assessed the effects of a Btk inhibitor, leflunomide metabolite analog (LFM-A13), on neutrophils. LFM-A13 decreased the tyrosine phosphorylation induced by fMet-Leu-Phe and inhibited the production of superoxide anions and the stimulation of adhesion, chemotaxis, and phospholipase D activity. We observed a decreased accumulation of phosphatidylinositol-3,4,5-trisphosphate in response to fMet-Leu-Phe in LFM-A13-pretreated cells even though the inhibitor had no direct effect on the lipid kinase activity of the p110 gamma or p85/p110 phosphatidylinositol 3-kinases or on the activation of p110 gamma by fMet-Leu-Phe. The phosphorylation of Akt and of extracellular signal-regulated kinases 1/2 and p38 were similarly inhibited by LFM-A13. LFM-A13 also negatively affected the translocation of Rac-2, RhoA, ADP ribosylation factor-1, Tec, Bmx, and Btk induced by fMet-Leu-Phe. The results of this study provide evidence for an involvement of Btk and possibly other Tec kinase family members in the regulation of the functional responsiveness of human neutrophils and link these events, in part at least, to the modulation of levels of phosphatidylinositol-3,4,5-trisphosphate.


Subject(s)
Amides/pharmacology , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Neutrophils/enzymology , Neutrophils/physiology , Nitriles/pharmacology , Protein-Tyrosine Kinases/antagonists & inhibitors , Protein-Tyrosine Kinases/metabolism , Adult , Agammaglobulinaemia Tyrosine Kinase , Chemotaxis, Leukocyte/drug effects , Enzyme Activation/drug effects , Humans , Neutrophils/drug effects , Neutrophils/metabolism , Phosphatidylinositol Phosphates/metabolism , Phospholipase D/metabolism , Phosphorylation/drug effects , Protein Transport/drug effects , Substrate Specificity/drug effects , Substrate Specificity/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...